New hope for bladder cancer patients: gene therapy trial launches
Disease control
Recruiting now
This study tests a new drug, EG-70, given directly into the bladder for people with a type of bladder cancer called non-muscle invasive bladder cancer (NMIBC). It is for patients whose cancer did not respond to standard BCG therapy, as well as those who have not had enough BCG tr…
Phase: PHASE1, PHASE2 • Sponsor: enGene, Inc. • Aim: Disease control
Last updated May 07, 2026 18:39 UTC